Amanda Maria Barros Alves

Dr. Amanda Maria Barros Alves

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2025 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
IRIvana Carneiro Romão
Ivana Carneiro Romão
AAAmanda Maria Barros Alves
Amanda Maria Barros Alves
TSTainá de Sousa Silva
Tainá de Sousa Silva
MMMárcia Machado Marinho
Márcia Machado Marinho
EMEmmanuel Silva Marinho
Emmanuel Silva Marinho
Helcio Silva Dos SantosHelcio Silva Dos Santos
Helcio Silva Dos Santos

12 June 2026 in Plants
Verified
Journal Article
Open access
PDF file
FRFázia Fernandes Galvão Rodrigues
Fázia Fernandes Galvão Rodrigues
NCNatalia Kelly Gomes de Carvalho
Natalia Kelly Gomes de Carvalho
Geane SouzaGeane Souza
Geane Souza
Helcio Silva Dos SantosHelcio Silva Dos Santos
Helcio Silva Dos Santos
Irwin Rose Alencar de MenezesIrwin Rose Alencar de Menezes
Irwin Rose Alencar de Menezes
JCJosé Galberto Martins Da Costa
José Galberto Martins Da Costa
Anxiety disorders are characterized by dysregulation of monoaminergic signaling and remain a significant therapeutic challenge due to limitations associated with current pharmacological treatments. In this context, the essential oil of Morisonia flexuosa (Capparaceae) seeds was chemically characterized and evaluated for anxiolytic-like activity in adult zebrafish. Chemical profiling by GC–MS and GC–FID revealed a predominance of isothiocyanates, particularly butyl isothiocyanate (42.60%) and isobutyl isothiocyanate (42.28%). Acute toxicity assessment demonstrated no lethality at the tested doses. Behavioral analyses showed a significant increase in light preference in the light/dark paradigm, with moderate locomotor reduction insufficient to account for the behavioral shift solely by sedation. Pharmacological antagonism assays indicated that the anxiolytic-like effect was predominantly mediated by 5-HT1 and 5-HT2A/2C receptors. Chemometric analyses (PCA, HCA, and heatmap) revealed statistical association between compound abundance and behavioral endpoints, supporting the contribution of major isothiocyanates within the tested model. Notably, the strongest behavioral response was observed at the lowest concentration, suggesting an ideal effective concentration range. Collectively, these findings provide the first evidence that an isothiocyanate-rich essential oil from M. flexuosa exerts serotonergic-involved anxiolytic-like effects in zebrafish and supports further mechanistic investigation of its neuropharmacological potential.

14 May 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
JCJosé Galberto Martins Da Costa
José Galberto Martins Da Costa
NCNatália Kelly Gomes De Carvalho
Natália Kelly Gomes De Carvalho
MSMariana Pereira da Silva
Mariana Pereira da Silva
DLDébora Odília Duarte Leite
Débora Odília Duarte Leite
GTGerson Javier Torres
Gerson Javier Torres
Helcio Silva Dos SantosHelcio Silva Dos Santos
Helcio Silva Dos Santos
Anxiety is a multifactorial pathology associated with oxidative stress and changes in different neurotransmitters in the central nervous system (CNS). Sarcomphalus joazeiro (Rhamnaceae) has a predicted effect on the CNS, being considered an alternative for pre-clinical investigations of anxiolytic drugs. The objective of this study is to evaluate the chemical composition, analyze the antioxidant capacity and the anxiolytic effect of the ethanolic extract of S. joazeiro leaves (EEFSJ) in zebrafish. The chemical profile was analyzed by liquid chromatography coupled to mass spectrometry (UPLC-PDA-ESI-QDA). Antioxidant action by DPPH• elimination and ABTS•⁺ capture assays. The 96 h acute toxicity and open field and light and dark tests, for sedative and anxiolytic evaluation, respectively, were applied in vivo, using zebrafish. It was possible to identify 11 compounds from the flavonoid and saponin class. EEFSJ exhibited a mean inhibitory concentration (IC50) of 185.2 ± 2.2 µg/mL and 74.17 ± 1.5 µg/mL against the DPPH• and ABTS•⁺ radicals, respectively. In vivo, EEFSJ demonstrated reduced locomotor activity and an anxiolytic effect similar to diazepam via GABAergic systems, without presenting toxicity within 96 h. These results suggest the safety of using EEFSJ for the development of clinical trials for the production of new anxiolytic drugs.